Characterizing metabolic changes in human colorectal cancer

Analytical and Bioanalytical Chemistry

Volumn 407, Issue 16, 2015, Pages 4581-4595

  Williams, Michael D ^a   Zhang, Xing ^a   Park, Jeong Jin ^a   Siems, William F ^a   Gang, David R ^a   Resar, Linda M S ^b   Reeves, Raymond ^a   Hill, Herbert H ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioanalytical methods; Cancer biomarkers; Colorectal cancer; Ion mobility mass spectrometry; Mass spectrometry ICP MS; Metabolomics

Indexed keywords

BIOCHEMISTRY; BIOMARKERS; DIAGNOSIS; DISCRIMINANT ANALYSIS; FATTY ACIDS; ION MOBILITY SPECTROMETERS; LEAST SQUARES APPROXIMATIONS; MASS SPECTROMETRY; METABOLISM; SPECTROMETRY; TUMORS;

BIOANALYTICAL METHODS; CANCER BIOMARKERS; COLORECTAL CANCER; ION MOBILITY-MASS SPECTROMETRY; METABOLOMICS;

DISEASES;

COLORECTAL TUMOR; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METASTASIS; PATHOLOGY; PROCEDURES;

CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; HUMANS; MASS SPECTROMETRY; NEOPLASM METASTASIS;

EID: 84938094391     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-015-8662-x     Document Type: Article

References (73)

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA: A Cancer J Clin 64:9-29. doi: 10.3322/caac.21208
2. American Cancer Society (2014) Colorectal cancer facts & figures 2014-2016. American Cancer Society, Atlanta
3. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674. doi: 10.1016/j.cell.2011.02.013
4. Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519-530
5. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033. doi: 10.1126/science.1160809
6. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13:472-482. doi: 10.1016/j.ccr.2008.05.005
7. Reeves R, Beckerbauer L (2001) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519:13-29
8. Fusco A, Fedele M (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7:899-910. doi: 10.1038/nrc2271
9. Resar LMS (2010) The high mobility group A1 gene: transforming inflammatory signals into cancer? Cancer Res 70:436-439. doi: 10.1158/0008-5472.CAN-09-1212
10. Grade M, Hörmann P, Becker S, Hummon AB, Wangsa D, Varma S et al (2007) Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res 67:41-56. doi: 10.1158/0008-5472.CAN-06-1514
11. Johnson KR, Lehn DA, Reeves R (1989) Alternative processing of mRNAs encoding mammalian chromosomal High-Mobility-Group Proteins HMG-I and HMG-Y. Mol Cell Biol 9:2114-2123
12. Reeves R (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277:63-81
13. Pedulla ML, Treff NR, Resar LM, Reeves R (2001) Sequence and analysis of the murine Hmgiy (Hmga1) gene locus. Gene 271:51-58
14. Belton A, Gabrovsky A, Bae YK, Reeves R, Iacobuzio-Donahue C, Huso DL et al (2012) HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS One 7:e30034. doi: 10.1371/journal.pone.0030034
15. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F et al (1996) High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13:2439-2446
16. Shah SN, Kerr C, Cope L, Zambidis E, Liu C, Hillion J et al (2012) HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS One 7:e48533. doi: 10.1371/journal.pone.0048533
17. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A et al (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499-507. doi: 10.1038/ng.127
18. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442. doi: 10.1038/415436a
19. Hristov AC, Cope L, Di Cello F, Reyes MD, Singh M, Hillion JA et al (2010) HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma. Modern Pathol 23:98-104. doi: 10.1038/modpathol.2009.139
20. Shah SN, Cope L, Poh W, Belton A, Roy S, Talbot CC et al (2013) HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells. PLoS One 8:e63419. doi: 10.1371/journal.pone.0063419
21. Roy S, Di Cello F, Kowalski J, Hristov AC, Tsai H-L, Bhojwani D et al (2013) HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia. Leuk Lymphoma 54:2565-2567. doi: 10.3109/10428194.2013.782610
22. Yanagisawa BL, Resar LM (2014) Hitting the bull's eye: targeting HMGA1 in cancer stem cells. Expert Rev Anticancer Ther 14:23-30. doi: 10.1586/14737140.2013.859988
23. Huso TH, Resar LM (2014) The high mobility group A1 molecular switch: turning on cancer - can we turn it off? Expert Opin Ther Targets 18:541-553. doi: 10.1517/14728222.2014.900045
24. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H et al (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69:4918-4925. doi: 10.1158/0008-5472.CAN-08-4806
25. Chan ECY, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A et al (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8:352-361. doi: 10.1021/pr8006232
26. Tessem M-B, Selnaes KM, Sjursen W, Trano G, Giskeodegard GF, Bathem TF et al (2010) Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis. J Proteome Res 9:3664-3670. doi: 10.1021/pr100176g
27. Chae Y-K, Kang W-Y, Kim S-H, Joo J-E, Han J-K, Hong B-W (2010) Combining information of common metabolites reveals global differences between colorectal cancerous and normal tissues. Bull Korean Chem Soc 31:379-383. doi: 10.5012/bkcs.2010.31.02.379
28. Piotto M, Moussallieh F-M, Dillmann B, Imperiale A, Neuville A, Brigand C et al (2008) Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy. Metabolomics 5:292-301. doi: 10.1007/s11306-008-0151-1
29. Mal M, Koh PK, Cheah PY, Chan ECY (2009) Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue. Rapid Commun Mass Spectrom 23:487-494. doi: 10.1002/rcm.3898
30. Jordan KW, Nordenstam J, Lauwers GY, Rothenberger DA, Alavi K, Garwood M et al (2009) Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy. Dis Colon Rectum 52:520-525. doi: 10.1007/DCR.0b013e31819c9a2c
31. Moreno A, Rey M, Montane JM, Alonso J, Arús C (1993) 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance. NMR Biomed 6:111-118
32. Moreno A, Arús C (1996) Quantitative and qualitative characterization of 1H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies. NMR Biomed 9:33-45. doi: 10.1002/(SICI)1099-1492(199602)9:1<33::AID-NBM391>3.0.CO;2-G
33. Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Suda Y, Sekine T et al (1999) Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res 90:419-424
34. Bertini I, Cacciatore S, Jensen BV, Schou JV, Johansen JS, Kruhoffer M et al (2011) Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res 72:356-364. doi: 10.1158/0008-5472.CAN-11-1543
35. Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M et al (2012) Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res 11:1354-1363. doi: 10.1021/pr201001a
36. Ritchie SA, Ahiahonu PWK, Jayasinghe D, Heath D, Liu J, Lu Y et al (2010) Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med 8:13. doi: 10.1186/1741-7015-8-13
37. Qiu Y, Cai G, Su M, Chen T, Liu Y, Xu Y et al (2010) Urinary metabonomic study on colorectal cancer. J Proteome Res 9:1627-1634. doi: 10.1021/pr901081y
38. Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y et al (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 8:4844-4850. doi: 10.1021/pr9004162
39. Ludwig C, Ward DG, Martin A, Viant MR, Ismail T, Johnson PJ et al (2009) Fast targeted multidimensional NMR metabolomics of colorectal cancer. Magn Reson Chem 47:S68-S73. doi: 10.1002/mrc.2519
40. Li S, Zhao X, Wu Z, Li Y, Zhu L, Cui B et al (2013) Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer. Fam Cancer 12:755-765. doi: 10.1007/s10689-013-9659-2
41. Nishiumi S, Kobayashi T, Ikeda A, Yoshie T, Kibi M, Izumi Y et al (2012) A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One 7:e40459. doi: 10.1371/journal.pone.0040459
42. Williams MD, Reeves R, Resar LS, Hill HH (2013) Metabolomics of colorectal cancer: past and current analytical platforms. Anal Bioanal Chem 405:5013-5030. doi: 10.1007/s00216-013-6777-5
43. Williams MD, Zhang X, Belton AS, Xian L, Huso T, Park J-J et al (2015) HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis. J Proteome Res 14:1420-1431. doi: 10.1021/pr501084s
44. Dwivedi P, Schultz AJ Jr, HHH (2010) Metabolic profiling of human blood by high-resolution ion mobility mass spectrometry (IM-MS). Int J Mass Spectrom 298:78-90. doi: 10.1016/j.ijms.2010.02.007
45. Dwivedi P, Hill HH (2008) A rapid analytical method for hair analysis using ambient pressure ion mobility mass spectrometry with electrospray ionization (ESI-IMMS). Int J Ion Mobil Spectrom 11:61-69. doi: 10.1007/s12127-008-0006-5
46. Kaplan K, Dwivedi P, Davidson S, Yang Q, Tso P, Siems W et al (2009) Monitoring dynamic changes in lymph metabolome of fasting and fed rats by electrospray ionization-ion mobility mass spectrometry (ESI-IMMS). Anal Chem 81:7944-7953. doi: 10.1021/ac901030k
47. Dwivedi P, Puzon G, Tam M, Langlais D, Jackson S, Kaplan K et al (2010) Metabolic profiling of Escherichia coli by ion mobility-mass spectrometry with MALDI ion source. J Mass Spectrom 45:1383-1393. doi: 10.1002/jms.1850
48. May JC (2012) Encyclopedia of drug metabolism and interactions, Chapter 9, Gas-phase ion mobility-mass spectrometry (IM-MS) and tandem IM-MS/MS strategies for metabolism studies and metabolomics. vol. 5. 1st ed. Wiley, Hoboken
49. Giles K, Pringle SD, Worthington KR, Little D, Wildgoose JL, Bateman RH (2004) Applications of a travelling wave-based radio-frequency-only stacked ring ion guide. Rapid Commun Mass Sperom 18:2401-2414. doi: 10.1002/rcm.1641
50. Malkar A, Devenport NA, Martin HJ, Patel P, Turner MA, Watson P et al (2013) Metabolic profiling of human saliva before and after induced physiological stress by ultra-high performance liquid chromatography-ion mobility-mass spectrometry. Metabolomics 9:1192-1201. doi: 10.1007/s11306-013-0541-x
51. Shah V, Castro-Perez JM, McLaren DG, Herath KB, Previs SF, Roddy TP (2013) Enhanced data-independent analysis of lipids using ion mobility-TOFMS E to unravel quantitative and qualitative information in human plasma: enhanced data-independent analysis of lipids. Rapid Commun Mass Spectrom 27:2195-2200. doi: 10.1002/rcm.6675
52. Ignatenko N, Gerner E, Besselsen D (2011) Defining the role of polyamines in colon carcinogenesis using mouse models. J Carcinog 10:10. doi: 10.4103/1477-3163.79673
53. Berdinskikh NK, Ignatenko NA, Zaletok SP, Ganina KP, Chorniy VA (1991) Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. Int J Cancer 47:496-498
54. Elitsur Y, Moshier JA, Murthy R, Barbish A, Luk GD (1992) Polyamine levels, ornithine decarboxylase (ODC) activity, and ODC-mRNA expression in normal and cancerous human colonocytes. Life Sci 50:1417-1424
55. Yerushalmi HF, Besselsen DG, Ignatenko NA, Blohm-Mangone KA, Padilla-Torres JL, Stringer DE et al (2006) Role of polyamines in arginine-dependent colon carcinogenesis inApcMin/+ mice. Mol Carcinog 45:764-773. doi: 10.1002/mc.20246
56. Bridoux MC, Ingalls AE (2010) Structural identification of long-chain polyamines associated with diatom biosilica in a Southern Ocean sediment core. Geochim Cosmochim Acta 74:4044-4057. doi: 10.1016/j.gca.2010.04.010
57. Linsalata M, Orlando A, Russo F (2014) Pharmacological and dietary agents for colorectal cancer chemoprevention: effects on polyamine metabolism (review). Int J Oncol. doi: 10.3892/ijo.2014.2597
58. Yoo B, Kong S-Y, Jang S-G, Kim K-H, Ahn S-A, Park W-S et al (2010) Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling. BMC Cancer 10:55. doi: 10.1186/1471-2407-10-55
59. Baenke F, Peck B, Miess H, Schulze A (2013) Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech 6:1353-1363. doi: 10.1242/dmm.011338
60. Hopperton KE, Duncan RE, Bazinet RP, Archer MC (2014) Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity. Exp Cell Res 320:302-310. doi: 10.1016/j.yexcr.2013.10.016
61. Zaidi N, Swinnen JV, Smans K (2012) ATP-citrate lyase: a key player in cancer metabolism. Cancer Res 72:3709-3714. doi: 10.1158/0008-5472.CAN-11-4112
62. Ide Y, Waki M, Hayasaka T, Nishio T, Morita Y, Tanaka H et al (2013) Human breast cancer tissues contain abundant phosphatidylcholine(36 : 1) with high stearoyl-CoA desaturase-1 expression. PLoS One 8:e61204. doi: 10.1371/journal.pone.0061204
63. Kurabe N, Hayasaka T, Ogawa M, Masaki N, Ide Y, Waki M et al (2013) Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4. Cancer Sci 104:1295-1302. doi: 10.1111/cas.12221
64. Ishikawa S, Tateya I, Hayasaka T, Masaki N, Takizawa Y, Ohno S et al (2012) Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer. PLoS One 7:e48873. doi: 10.1371/journal.pone.0048873
65. Kingsnorth AN, Lumsden AB, Wallace HM (1984) Polyamines in colorectal cancer. Br J Surg 71:791-794
66. Balendiran GK, Dabur R, Fraser D (2004) The role of glutathione in cancer. Cell Biochem Funct 22:343-352. doi: 10.1002/cbf.1149
67. Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA et al (2013) Role of glutathione in cancer progression and chemoresistance. Oxidative Med Cell Longev 2013:1-10. doi: 10.1155/2013/972913
68. Hussain SP, Hofseth LJ, Harris CC (2003) Radical causes of cancer. Nat Rev Cancer 3:276-285. doi: 10.1038/nrc1046
69. Kondo T, Iida T (1997) gamma-GCS and glutathione - new molecular targets in cancer treatment. Gan To Kagaku Ryoho 24:2219-2225
70. Carretero J, Obrador E, Anasagasti MJ, Martin JJ, Vidal-Vanaclocha F, Estrela JM (1999) Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells. Clin Exp Metastasis 17:567-574
71. Duthie SJ (2011) Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 34:101-109. doi: 10.1007/s10545-010-9128-0
72. Jerby L, Wolf L, Denkert C, Stein GY, Hilvo M, Oresic M et al (2012) Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res 72:5712-5720. doi: 10.1158/0008-5472.CAN-12-2215
73. Williams MD (2014) Discovering biochemical signatures of disease: metabolomics of colorectal cancer via ion mobility mass spectrometry. Doctoral Dissertation, Washington State University, Department of Chemistry